AACR, EmergingMed collaborate to connect cancer patients with clinical trials in link with SU2C broadcast The American Association for Tumor Analysis announces its collaboration with the clinical trial navigation system EmergingMed, to connect patients with clinical trials in connection to the Stand Up To Cancers broadcast which occurred on Sept. 10, at 8 p http://www.tadacip20mg.net .m. EDT & PDT / 7 p.m. CDT. The AACR-SU2C Clinical Trials Finder provides a resource for cancer patients and their loved ones to recognize clinical trials that may be suitable for their particular diagnosis, stage and treatment history. ‘The AACR is thrilled to partner with EmergingMed, in conjunction with the landmark SU2C broadcast on Sept. 10, to be able to help individuals locate clinical trials for which they qualify,’ stated Margaret Foti, Ph.D., M.D.
‘These dedicated Congressional leaders obviously understand the need to continue and certainly strengthen the nation’s efforts against the 200 illnesses we call cancers. We must pursue every avenue to conquer cancer tumor with a feeling of urgency, and research in preventing, treating and detecting cancer is essential to public health.’ The resolution recognizes the researchers and clinicians across the United States dedicated to fighting malignancy and highlights key malignancy statistics. Among them, the resolution notes that the five-year survival price for all cancers mixed has increased from 50 % to 65 % during the past 30 years. While there are 12 million cancers survivors in the usa currently, more than 500,000 Americans die from cancer each full year. The AACR believes that it is vitally important to underscore the worthiness of cancer research at this juncture, as there are several promising developments against cancers in the pipeline just waiting to end up being translated for the good of cancer patients..